juniper semaglutide Warning issued after advert suggests NHS staff endorse popular weight loss drugs Wegovy Weight Loss Injections UK

New data is shedding light on a potential link between GLP-1 receptor agonists and long-term vision outcomes, with findings suggesting these therapies may be associated with a lower risk of legal blindness in patients with type 2 diabetes

The evolution of the GLP-1RA class to include an oral agent could facilitate the use of these agents earlier in the diabetes treatment cascade owing to wider acceptance from patients and healthcare professionals

New research highlights the use of #GLP1 receptor agonists (like semaglutide &amp

The global GLP-1 market is on a significant growth trajectory, anticipated to rise from an estimated $44.5 million in 2023 to $95.4 million by 2031,...